It s Time for a Chief Adherence Officer

The pharma revenue engine is stalling. A full 78% of Americans, according to the Kaiser Health Tracking Poll , say drug companies making too much money is a major reason why their healthcare costs have been rising, up from 62% who felt that way in 2014. The political winds have shifted and Powered by WPeMatico Continue reading It s Time for a Chief Adherence Officer

FDA After Gottlieb: Thorny Issues, Political Challenges

During the nearly two years that Scott Gottlieb headed FDA, the agency achieved record approval rates for new drugs and generics and advanced important innovations in clinical research and benefit/risk assessment to enhance R&D and competition in the biopharmaceutical industry. The agency is Powered by WPeMatico Continue reading FDA After Gottlieb: Thorny Issues, Political Challenges

Empowering Women Entrepreneurs in Healthcare

Advancements in technology are changing the face of healthcare and creating opportunities for entrepreneurship across the board. At the forefront of this transformation are woman-owned companies that are embracing innovation and making important contributions to fields like consulting, patient e Powered by WPeMatico Continue reading Empowering Women Entrepreneurs in Healthcare

Time is Running Out for Pharma to Change Course

Tom Kottler It s no surprise that pharmaceutical giants Pfizer and Merck raised drug prices once again. While the companies may take a bit of political heat now, they know that in the long run this approach will do what it has consistently done before. After all, why give up on the stra Powered by WPeMatico Continue reading Time is Running Out for Pharma to Change Course

Administration Acts Fast to Smooth Transition to New FDA Commissioner

Health and Human Services (HHS) Secretary Alex Azar wasted little time in naming a new leader for FDA. Norman (Ned) Sharpless, director of the National Cancer Institute (NCI) at the National Institutes of Health (NIH), will become acting commissioner next month as Scott Gottlieb departs the agen Powered by WPeMatico Continue reading Administration Acts Fast to Smooth Transition to New FDA Commissioner